Aclaris Therapeutics's total assets for Q1 2026 were $198.72M, an increase of 23.84% from the previous quarter. ACRS total liabilities were $55.07M for the fiscal quarter, a -4.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.